THE GROUP .
Working on biocompatible nanoparticle systems for use as MRI contrast agents.
Working on parmagnetic inorganic-organic hybrid nanoparticle imaging systems.
Working on electrochemical microfluidics and kinetics quantification in diagnostics.
Investigating metabolic plasticity in prostate cancer bone metastases and novel circulating tumour cell (CTC) isolation methodology. More specifically, developing nanoparticle and microfluidic-based approaches for detection and isolation of prostate cancer CTCs.
Developing novel electrochemical ion sensing methodologies, and exploring the ion sensing performance of a range of supramolecular hosts in solution, and at receptive films.
Working on nanoparticle capture systems and parkinsons diagnostics.
Working on electrochemical microfluidics and parkinsons diagnostics.
Working on NOT chasing wild animals and "improving" the group leaders 10k time
![photo 3](https://jjdgroup.co.uk/wp-content/uploads/2023/12/photo-3-scaled.jpg)
![IMG_2423](https://jjdgroup.co.uk/wp-content/uploads/2024/06/IMG_2423-scaled.jpeg)
![photo 2](https://jjdgroup.co.uk/wp-content/uploads/2023/12/photo-2-scaled.jpg)
FORMER MEMBERS IN ACADEMIA .
Multiple previous members of the group are now in academic positions around the world, including:
- Dr Robert Hein (University of Muenster)
- Dr Abdul Ismail (Un diversity of Paris-Saclay)
- Dr Jan Tkac (Slocak Academy of Sciences, Slovakia)
- Dr Xiliang Luo (Qingdao University of Science and Technology)
- Dr Joshua Lehr (University of Salford)
- Dr Gemma Louise-Davies (University of Birmingham)
- Dr Mohamed Sharafeldin (University of Otago, New Zealand)